 Karin Zemski Berry
Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phospholipids | 7 | 2023 | 197 | 1.440 |
Why?
| | Phosphatidylethanolamines | 5 | 2013 | 66 | 1.280 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2017 | 134 | 0.930 |
Why?
| | Lipids | 6 | 2022 | 580 | 0.880 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 7 | 2016 | 162 | 0.690 |
Why?
| | Arachidonate 5-Lipoxygenase | 2 | 2016 | 45 | 0.610 |
Why?
| | Insulin Resistance | 5 | 2023 | 1072 | 0.600 |
Why?
| | Plasmalogens | 3 | 2013 | 6 | 0.600 |
Why?
| | Isotope Labeling | 2 | 2009 | 69 | 0.570 |
Why?
| | Ozone | 1 | 2016 | 99 | 0.500 |
Why?
| | Tandem Mass Spectrometry | 5 | 2023 | 412 | 0.450 |
Why?
| | Optic Nerve | 1 | 2013 | 65 | 0.440 |
Why?
| | Macrophages, Alveolar | 1 | 2016 | 348 | 0.430 |
Why?
| | Computational Biology | 1 | 2017 | 530 | 0.420 |
Why?
| | para-Aminobenzoates | 2 | 2010 | 5 | 0.420 |
Why?
| | Docosahexaenoic Acids | 4 | 2023 | 69 | 0.410 |
Why?
| | Retina | 1 | 2013 | 263 | 0.380 |
Why?
| | Imaging, Three-Dimensional | 1 | 2011 | 512 | 0.290 |
Why?
| | Acrolein | 1 | 2007 | 23 | 0.290 |
Why?
| | Triglycerides | 5 | 2022 | 467 | 0.260 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2096 | 0.250 |
Why?
| | Glycerylphosphorylcholine | 1 | 2005 | 5 | 0.240 |
Why?
| | Methane | 1 | 2005 | 41 | 0.240 |
Why?
| | Lung | 1 | 2017 | 3561 | 0.230 |
Why?
| | Free Radicals | 1 | 2005 | 99 | 0.230 |
Why?
| | Oxidation-Reduction | 3 | 2020 | 923 | 0.230 |
Why?
| | Liposomes | 4 | 2010 | 146 | 0.230 |
Why?
| | Fatty Acids, Unsaturated | 3 | 2016 | 84 | 0.220 |
Why?
| | Symporters | 1 | 2023 | 52 | 0.220 |
Why?
| | Chromatography, Liquid | 3 | 2023 | 347 | 0.220 |
Why?
| | Mitochondrial Diseases | 1 | 2023 | 77 | 0.210 |
Why?
| | Oxygen | 2 | 2022 | 854 | 0.210 |
Why?
| | Placenta | 3 | 2023 | 628 | 0.210 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2023 | 122 | 0.200 |
Why?
| | Glycerol | 1 | 2022 | 84 | 0.200 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2010 | 470 | 0.200 |
Why?
| | Intra-Abdominal Fat | 1 | 2022 | 77 | 0.200 |
Why?
| | Overnutrition | 1 | 2022 | 30 | 0.190 |
Why?
| | Mass Spectrometry | 1 | 2005 | 633 | 0.190 |
Why?
| | Fetal Blood | 1 | 2022 | 270 | 0.180 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2016 | 194 | 0.180 |
Why?
| | Adipose Tissue | 2 | 2022 | 545 | 0.180 |
Why?
| | Immunity | 1 | 2020 | 121 | 0.170 |
Why?
| | Mice | 9 | 2023 | 14872 | 0.160 |
Why?
| | Heart Diseases | 1 | 2022 | 331 | 0.160 |
Why?
| | Cell Cycle Proteins | 2 | 2016 | 551 | 0.160 |
Why?
| | Animals | 11 | 2023 | 31709 | 0.150 |
Why?
| | Fetal Growth Retardation | 1 | 2022 | 468 | 0.140 |
Why?
| | Lysophospholipids | 2 | 2008 | 65 | 0.140 |
Why?
| | Arachidonic Acid | 2 | 2009 | 116 | 0.140 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2022 | 452 | 0.130 |
Why?
| | Humans | 19 | 2023 | 114709 | 0.130 |
Why?
| | Neutrophils | 3 | 2007 | 1176 | 0.130 |
Why?
| | Obesity | 6 | 2023 | 2508 | 0.130 |
Why?
| | Biological Transport | 1 | 2017 | 374 | 0.130 |
Why?
| | Molecular Structure | 2 | 2007 | 434 | 0.120 |
Why?
| | Mice, Inbred C57BL | 3 | 2023 | 4694 | 0.120 |
Why?
| | Sulfoglycosphingolipids | 1 | 2013 | 3 | 0.110 |
Why?
| | Cell Line | 2 | 2010 | 2637 | 0.110 |
Why?
| | Photoreceptor Cells, Vertebrate | 1 | 2013 | 25 | 0.110 |
Why?
| | Colitis | 1 | 2016 | 223 | 0.110 |
Why?
| | Prostatic Neoplasms | 1 | 2020 | 921 | 0.110 |
Why?
| | Retinal Pigment Epithelium | 1 | 2013 | 58 | 0.110 |
Why?
| | Interferon-gamma | 1 | 2016 | 719 | 0.100 |
Why?
| | Ceramides | 2 | 2023 | 91 | 0.100 |
Why?
| | Sphingolipids | 2 | 2023 | 57 | 0.100 |
Why?
| | Culture Media, Conditioned | 2 | 2022 | 105 | 0.100 |
Why?
| | Phosphatidylcholines | 2 | 2022 | 133 | 0.100 |
Why?
| | Pregnancy | 4 | 2023 | 5520 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 1727 | 0.090 |
Why?
| | Organ Specificity | 1 | 2011 | 268 | 0.090 |
Why?
| | 4-Aminobenzoic Acid | 1 | 2009 | 6 | 0.080 |
Why?
| | Eicosanoids | 2 | 2009 | 54 | 0.080 |
Why?
| | Female | 8 | 2023 | 59523 | 0.080 |
Why?
| | Arachidonate 12-Lipoxygenase | 1 | 2009 | 13 | 0.080 |
Why?
| | Arachidonate 15-Lipoxygenase | 1 | 2009 | 16 | 0.080 |
Why?
| | Apolipoproteins E | 1 | 2009 | 80 | 0.080 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 93 | 0.080 |
Why?
| | Monoglycerides | 1 | 2008 | 2 | 0.080 |
Why?
| | Peritonitis | 1 | 2009 | 77 | 0.080 |
Why?
| | HL-60 Cells | 1 | 2007 | 28 | 0.070 |
Why?
| | Secretory Vesicles | 1 | 2007 | 24 | 0.070 |
Why?
| | Neutrophil Activation | 1 | 2007 | 94 | 0.070 |
Why?
| | Calcimycin | 1 | 2005 | 47 | 0.060 |
Why?
| | Ionophores | 1 | 2005 | 22 | 0.060 |
Why?
| | Atherosclerosis | 1 | 2009 | 341 | 0.060 |
Why?
| | Calcium Signaling | 1 | 2007 | 217 | 0.060 |
Why?
| | Models, Molecular | 1 | 2010 | 1369 | 0.060 |
Why?
| | Hydrocarbons | 1 | 2005 | 29 | 0.060 |
Why?
| | Lipid Peroxidation | 1 | 2005 | 139 | 0.060 |
Why?
| | Muscle, Skeletal | 2 | 2023 | 1473 | 0.060 |
Why?
| | Membrane Lipids | 1 | 2005 | 87 | 0.060 |
Why?
| | Ubiquinone | 1 | 2023 | 21 | 0.060 |
Why?
| | Aldehydes | 1 | 2005 | 138 | 0.060 |
Why?
| | Electron Transport | 1 | 2023 | 108 | 0.050 |
Why?
| | Signal Transduction | 1 | 2016 | 4516 | 0.050 |
Why?
| | Models, Chemical | 1 | 2005 | 248 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 20 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2013 | 6347 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2023 | 138 | 0.050 |
Why?
| | Arachidonic Acids | 1 | 2022 | 56 | 0.050 |
Why?
| | Acyltransferases | 1 | 2022 | 46 | 0.050 |
Why?
| | Lysophosphatidylcholines | 1 | 2022 | 30 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 42 | 0.050 |
Why?
| | Adult Children | 1 | 2022 | 21 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 83 | 0.050 |
Why?
| | Subcutaneous Fat | 1 | 2022 | 70 | 0.050 |
Why?
| | Rheology | 1 | 2022 | 86 | 0.050 |
Why?
| | Ultraviolet Rays | 1 | 2005 | 363 | 0.050 |
Why?
| | Fetal Heart | 1 | 2022 | 37 | 0.050 |
Why?
| | Interleukin-13 | 1 | 2022 | 122 | 0.050 |
Why?
| | Carnitine | 1 | 2022 | 62 | 0.050 |
Why?
| | Fatty Acids | 1 | 2005 | 381 | 0.050 |
Why?
| | Dinoprostone | 1 | 2022 | 184 | 0.050 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2023 | 185 | 0.050 |
Why?
| | Macrophages | 1 | 2008 | 1263 | 0.050 |
Why?
| | Phosphates | 1 | 2022 | 159 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 237 | 0.050 |
Why?
| | RNA, Small Interfering | 1 | 2023 | 535 | 0.050 |
Why?
| | Cardiomegaly | 1 | 2022 | 157 | 0.050 |
Why?
| | Cell Membrane | 1 | 2005 | 680 | 0.050 |
Why?
| | Ranolazine | 1 | 2020 | 22 | 0.050 |
Why?
| | Ultrasonography, Prenatal | 1 | 2022 | 236 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2023 | 2553 | 0.050 |
Why?
| | PPAR gamma | 1 | 2022 | 182 | 0.050 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 2711 | 0.040 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2020 | 195 | 0.040 |
Why?
| | Tumor Burden | 1 | 2020 | 259 | 0.040 |
Why?
| | Birth Weight | 1 | 2022 | 440 | 0.040 |
Why?
| | Male | 4 | 2022 | 55609 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2022 | 676 | 0.040 |
Why?
| | Fetus | 1 | 2022 | 700 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2020 | 347 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2020 | 444 | 0.040 |
Why?
| | Dendritic Cells | 1 | 2020 | 435 | 0.040 |
Why?
| | Glucose | 1 | 2022 | 897 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1140 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2016 | 2570 | 0.030 |
Why?
| | Dextran Sulfate | 1 | 2016 | 70 | 0.030 |
Why?
| | Ions | 1 | 2016 | 59 | 0.030 |
Why?
| | Aged | 1 | 2013 | 19074 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2020 | 688 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2020 | 1040 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 6116 | 0.030 |
Why?
| | Rats | 1 | 2022 | 4958 | 0.030 |
Why?
| | Middle Aged | 1 | 2013 | 26738 | 0.030 |
Why?
| | Insulin | 1 | 2023 | 2080 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4410 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2016 | 1083 | 0.030 |
Why?
| | Brain | 1 | 2023 | 2371 | 0.020 |
Why?
| | Cells, Cultured | 2 | 2008 | 3886 | 0.020 |
Why?
| | Peritoneal Lavage | 1 | 2009 | 7 | 0.020 |
Why?
| | Phosphatidylglycerols | 1 | 2008 | 20 | 0.020 |
Why?
| | Organ Size | 1 | 2009 | 436 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2009 | 270 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2007 | 14 | 0.020 |
Why?
| | Spleen | 1 | 2009 | 487 | 0.020 |
Why?
| | Type C Phospholipases | 1 | 2007 | 65 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2016 | 3535 | 0.020 |
Why?
| | Cholesterol | 1 | 2008 | 367 | 0.020 |
Why?
| | Aorta | 1 | 2009 | 386 | 0.020 |
Why?
| | Isoprostanes | 1 | 2005 | 4 | 0.020 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2005 | 6 | 0.020 |
Why?
| | Thromboxanes | 1 | 2005 | 14 | 0.020 |
Why?
| | Leukotrienes | 1 | 2005 | 35 | 0.020 |
Why?
| | Prostaglandins | 1 | 2005 | 77 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2008 | 460 | 0.010 |
Why?
|
|
Zemski Berry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|